{"DataElement":{"publicId":"4030358","version":"1","preferredName":"Maintenance Therapy Post Platinum-Based Chemotherapy Administered Indicator","preferredDefinition":"information related to the administration of medication for the continuation of treatment for an extended period of time to prevent relapse happening at a time subsequent to the use of synthetic or naturally-occurring chemicals for the treatment of diseases derived from or containing platinum.","longName":"Main_Post_Plat_Chem_Admi_Main_","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"4030353","version":"1","preferredName":"Maintenance Therapy Post Platinum-Based Chemotherapy Administered","preferredDefinition":"information related to the administration of medication for the continuation of treatment for an extended period of time to prevent relapse happening at a time subsequent to the use of synthetic or naturally-occurring chemicals for the treatment of diseases derived from or containing platinum.","longName":"Main_Post_Plat_Chem_Admi","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2737721","version":"1","preferredName":"Maintenance Therapy","preferredDefinition":"Treatment that is given to help a primary (original) treatment keep working. Maintenance therapy is often given to help keep cancer in remission.","longName":"C15688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49862DD1-E502-1DB0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-03-28","modifiedBy":"SBREXT","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4030351","version":"1","preferredName":"Post Platinum-Based Chemotherapy Administered","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.:Derived from or containing platinum.:The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, it is particularly used to refer to the use of chemical-based agents to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.:The act of having given something (e.g., a medication or test).","longName":"C38008:C25620:C15632:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Platinum-Based","conceptCode":"C25620","definition":"Derived from or containing platinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A0C12-AABA-3C1E-E040-BB89AD4346EF","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A0C12-AACB-3C1E-E040-BB89AD4346EF","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4030355","version":"1","preferredName":"Maintenance Therapy Administered Indicator","preferredDefinition":"information related to the determination whether the act of administration of a continuation of treatment for an extended period of time to prevent relapse occured.","longName":"Main_Admi_Indi","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8A0C12-AB52-3C1E-E040-BB89AD4346EF","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","deletedIndicator":"No"},{"value":"Yes-biologic maintenance chemotherapy","valueDescription":"Yes Biological Maintenance Therapy","ValueMeaning":{"publicId":"4030356","version":"1","preferredName":"Yes Biological Maintenance Therapy","longName":"4030356","preferredDefinition":"The affirmative response to a question.: Pertaining to biology or to life and living things.: Continuation of treatment for an extended period of time to prevent relapse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Biological","conceptCode":"C28226","definition":"Pertaining to biology or to life and living things.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A0C12-AB08-3C1E-E040-BB89AD4346EF","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8A0C12-AB21-3C1E-E040-BB89AD4346EF","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","deletedIndicator":"No"},{"value":"Yes-cytotoxic maintenance chemotherapy","valueDescription":"Yes Cytotoxic Chemotherapy Maintenance Therapy","ValueMeaning":{"publicId":"4030357","version":"1","preferredName":"Yes Cytotoxic Chemotherapy Maintenance Therapy","longName":"4030357","preferredDefinition":"The affirmative response to a question.: Anticancer drugs that kill cells, especially cancer cells.: Continuation of treatment for an extended period of time to prevent relapse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cytotoxic Chemotherapy","conceptCode":"C15681","definition":"A drug therapy that is used to destroy cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A0C12-AB2F-3C1E-E040-BB89AD4346EF","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8A0C12-AB48-3C1E-E040-BB89AD4346EF","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4030354","version":"1","preferredName":"Maintenance Therapy Administered Indicator","preferredDefinition":"Continuation of treatment for an extended period of time to prevent relapse.:The act of having given something (e.g., a medication or test).:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C15688:C25382:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A0C12-AAE0-3C1E-E040-BB89AD4346EF","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"ONEDATA","dateModified":"2013-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A0C12-AAF1-3C1E-E040-BB89AD4346EF","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"REEVESD","dateModified":"2014-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"}]}],"AlternateNames":[{"name":"Main_Post_Plat_Chem_Admi_Main_","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Did the patient have maintena","type":"Preferred Question Text","description":"Did the patient have maintenance therapy following front-line platinum-taxane chemotherapy?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8A701B-79C3-DF68-E040-BB89AD433D67","latestVersionIndicator":"Yes","beginDate":"2013-12-27","endDate":null,"createdBy":"REBOYJ","dateCreated":"2013-12-27","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}